Amphastar Pharma Revenue, Profits - AMPH Quarterly Income Statement

Add to My Stocks
$19.44 $0.13 (0.66%) AMPH stock closing price Mar 20, 2018 (Closing)

AMPH stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Amphastar Pharma stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from 65.19M to 57.92M and how operating and non operating activities have impacted the AMPH stock. One also needs to look at Amphastar Pharma assets, operating expenses and Amphastar Pharma free cash flow. The Amphastar Pharma profit and loss statement shows revenue of $57.92M for 2017 Q3. Revenue has decreased by -11.15% QoQ for AMPH stock.

View and download details of revenue and profits for Amphastar Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Amphastar Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)37.27M38.44M33.84M43.59M36.61M36.31M34.46M43.75M46.29M
Amphastar Pharma Gross Profit
Research & Development Expense10.04M10.73M11.25M12.61M9.72M10.48M8.38M8.67M11.11M
Selling General & Admin Expense13.42M13.83M10.17M11.87M12.09M10.9M12.43M10.16M10.2M
Income Before Depreciation Depletion Amortization-2.82M2.18M1.4M-4.5M5.79M10.33M4.07M14.37M-3.74M
Depreciation Depletion Amortization---------
Non Operating Income1.09M1.22M--0.06M--0.27M--3.82M-0.29M
Interest Expense---------
Amphastar Pharma Pretax Income
Provision for Income Taxes-2.16M1.2M--1.87M2.11M2.85M1.32M2.8M-1.26M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-1.97M--2.74M3.89M6.9M2.49M7.53M-3.01M
Extraordinary Items & Discontinued Operations---------
Amphastar Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS48.22M47.87M48.06M46.1M47.95M45.97M46.81M46.71M45.31M
Average Shares used to compute Basic EPS46.1M46.03M46.07M46.1M45.4M44.96M45.04M45.09M45.31M
Income Before Nonrecurring Items3.5M5.43M1.39M-2.74M3.89M6.15M3.04M7.76M-3.01M
Income from Nonrecurring Items-3.32M-3.46M-0.5M----0.55M-0.23M-
Amphastar Pharma Earnings Per Share Basic Net
Amphastar Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.070.110.03-
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Amphastar Pharma stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that AMPH stock has a topline or revenue of $57.92M for 2017 Q3 as per this Amphastar Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Amphastar Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the AMPH income statement, one can check the Amphastar Pharma historical stock prices to check how the price has moved with time.

Amphastar Pharma Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Net Profit Margin
Dividend Yield

Other Income Statements - Amphastar Pharmaceuticals Inc Industry Peers

AxoGen income statement, Halozyme Therapeutics income statement, Sanofi income statement, Teligent income statement